Diego Vergani Selected Research

liver antigen LA-1

4/2014	Diagnostic criteria of autoimmune hepatitis.
5/2011	Identification of T cell epitopes on soluble liver antigen in Chinese patients with auto-immune hepatitis.
11/2004	Antibodies to soluble liver antigen and alpha-enolase in patients with autoimmune hepatitis.
3/2004	Targets of antibodies to soluble liver antigen in patients with autoimmune hepatitis.
3/2002	Antibodies to conformational epitopes of soluble liver antigen define a severe form of autoimmune liver disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Diego Vergani Research Topics

Disease

55	Autoimmune Hepatitis 10/2022 - 03/2002
35	Liver Diseases (Liver Disease) 01/2022 - 01/2002
25	Hepatitis 01/2022 - 06/2008
19	Biliary Liver Cirrhosis (Primary Biliary Cirrhosis) 04/2022 - 01/2002
14	Sclerosing Cholangitis 10/2022 - 06/2008
14	Fibrosis (Cirrhosis) 01/2021 - 09/2007
12	Acute Liver Failure (Fulminant Hepatic Failure) 01/2020 - 08/2002
11	Infections 01/2021 - 07/2002
9	End Stage Liver Disease 04/2022 - 02/2007
8	Inflammation (Inflammations) 01/2018 - 06/2008
6	Chronic Hepatitis C 01/2019 - 07/2002
6	Bile Duct Diseases (Bile Duct Disease) 02/2016 - 09/2011
5	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 10/2022 - 08/2002
5	Autoimmune Diseases (Autoimmune Disease) 01/2022 - 08/2002
5	Disease Progression 12/2019 - 03/2002
4	Hepatitis B 05/2011 - 09/2005
3	Necrosis 11/2021 - 07/2007
3	Brain Diseases (Brain Disorder) 03/2013 - 07/2006
3	Virus Diseases (Viral Diseases) 11/2007 - 05/2004
2	Genetic Predisposition to Disease (Genetic Predisposition) 10/2021 - 12/2004
2	Cholestasis 12/2019 - 01/2015
2	Hepatitis C 12/2018 - 06/2005
2	Hypergammaglobulinemia (Hyperimmunoglobulinemia) 01/2018 - 12/2016
2	Crohn Disease (Crohn's Disease) 04/2011 - 07/2006
2	Rubella (German Measles) 04/2011 - 12/2002
1	Late Onset Disorders 01/2022
1	Liver Failure 01/2021
1	Gallstones (Gallstone) 01/2021
1	Chronic Hepatitis B 01/2021
1	Intrahepatic Cholestasis of Pregnancy 01/2021
1	COVID-19 01/2021
1	Cholelithiasis 01/2021
1	Hepatitis E 11/2018
1	Hypersensitivity (Allergy) 01/2018

Drug/Important Bio-Agent (IBA)

50	AutoantibodiesIBA 10/2022 - 01/2002
24	Immunoglobulin G (IgG)IBA 01/2022 - 01/2002
21	AntibodiesIBA 12/2018 - 01/2002
13	Transaminases (Aminotransferases)IBA 01/2022 - 09/2009
9	AntigensIBA 09/2014 - 03/2002
8	Peptides (Polypeptides)IBA 02/2015 - 07/2002
8	AutoantigensIBA 09/2014 - 08/2002
7	CytokinesIBA 11/2017 - 08/2005
7	Cytochrome P-450 CYP2D6 (CYP2D6)IBA 09/2014 - 07/2002
6	SteroidsIBA 01/2017 - 08/2009
6	CytochromesIBA 11/2015 - 02/2003
5	Antinuclear AntibodiesIBA 01/2022 - 04/2004
5	Azathioprine (Imuran)FDA LinkGeneric 01/2020 - 08/2009
5	liver antigen LA-1IBA 04/2014 - 03/2002
4	HLA Antigens (Human Leukocyte Antigens)IBA 10/2021 - 12/2004
4	Ursodeoxycholic Acid (Urso)FDA LinkGeneric 01/2021 - 01/2015
4	InterferonsIBA 01/2019 - 06/2005
4	Interleukin-10 (Interleukin 10)IBA 09/2015 - 07/2006
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2014 - 07/2006
4	InterleukinsIBA 04/2014 - 07/2007
4	Acetaminophen (Paracetamol)FDA LinkGeneric 04/2014 - 07/2006
4	HLA-DR Antigens (HLA-DR)IBA 04/2014 - 07/2006
4	Immunoglobulins (Immunoglobulin)IBA 01/2014 - 11/2007
4	Proteins (Proteins, Gene)FDA Link 07/2013 - 07/2002
4	Oxidoreductases (Dehydrogenase)IBA 05/2009 - 01/2004
4	EpitopesIBA 06/2005 - 03/2002
3	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 10/2022 - 06/2008
3	Lamivudine (Epivir)FDA Link 01/2021 - 02/2006
3	Biomarkers (Surrogate Marker)IBA 12/2019 - 07/2006
3	Interleukin-4 (Interleukin 4)IBA 07/2013 - 07/2007
2	Antiviral Agents (Antivirals)IBA 01/2021 - 01/2019
2	Infliximab (Remicade)FDA Link 01/2018 - 09/2017
2	Pharmaceutical PreparationsIBA 01/2017 - 02/2008
2	Alanine Transaminase (SGPT)IBA 11/2015 - 06/2011
2	Interleukin-2 (IL2)IBA 09/2015 - 07/2007
2	Alcohol Dehydrogenase (Alcohol Dehydrogenase (NAD+))IBA 02/2015 - 07/2013
2	Interleukin-17 (Interleukin 17)IBA 01/2015 - 06/2012
2	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 05/2011 - 01/2004
2	Interferon-alpha (Interferon Alfa)IBA 03/2011 - 02/2006
2	ImmunosorbentsIBA 12/2010 - 07/2006
2	EnzymesIBA 12/2010 - 07/2006
2	Pyruvate Dehydrogenase Complex (Dehydrogenase Complex, Pyruvate)IBA 05/2009 - 09/2008
2	AcidsIBA 05/2009 - 11/2003
2	Pyruvic Acid (Pyruvate)IBA 06/2004 - 01/2004
1	HLA-DRB1 Chains (HLA DRB1)IBA 01/2022
1	Monoclonal AntibodiesIBA 11/2021
1	Biological ProductsIBA 11/2021
1	Alkaline PhosphataseIBA 01/2021
1	2019-nCoV Vaccine mRNA-1273IBA 01/2021
1	Phospholipids (Phosphatides)FDA LinkGeneric 01/2021
1	peginterferon alfa-2a (Pegasys)FDA Link 01/2021
1	entecavir FDA Link 01/2021
1	COVID-19 VaccinesIBA 01/2021
1	Messenger RNA (mRNA)IBA 01/2021
1	Mycophenolic Acid (Cellcept)FDA LinkGeneric 01/2020
1	Prednisone (Sone)FDA LinkGeneric 01/2020
1	Adalimumab (Humira)FDA Link 01/2018
1	Immunologic Factors (Immunomodulators)IBA 01/2018
1	Vitamin D FDA LinkGeneric 01/2018
1	azidoiodophenethylamidosuccinylcymarin (AISC)IBA 11/2017
1	Rituximab (Mabthera)FDA Link 09/2017
1	Antimalarials (Antimalarial Agents)IBA 01/2017
1	proguanil drug combination atovaquone (malarone)FDA Link 01/2017

Therapy/Procedure

25	Liver Transplantation 04/2022 - 03/2002
9	Transplantation 12/2018 - 03/2011
6	Therapeutics 01/2021 - 08/2002